<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nodular lymphocyte-predominant Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NLPHL</z:e>) is a rare subtype of Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The histological patterns of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NLPHL</z:e> variants are characterized by different localizations of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells, intranodular and perinodular and by the varying composition of the microenvironment </plain></SENT>
<SENT sid="2" pm="."><plain>T-cell/histiocyte-rich B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> may be the result of an aggressive transformation of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NLPHL</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Classical lymphocyte-rich Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> can usually be clearly distinguished from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NLPHL</z:e> by the immunophenotype of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="4" pm="."><plain>Further differential diagnoses include follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and the follicular variant of peripheral T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Angioimmunoblastic T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> with CD20-positive blasts represents a differential diagnosis to the diffuse variants of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NLPHL</z:e> </plain></SENT>
</text></document>